CONTEGRA
Report
- Report Number
- 2025587-2015-01234
- Event Type
- Injury
- Date Received
- November 24, 2015
- Date of Event
- March 9, 2014
- Report Date
- December 29, 2015
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- MWH
- PMA / PMN Number
- H020003
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). TITLE: WHICH TYPE OF CONDUIT TO CHOOSE FOR RIGHT VENTRICULAR OUTFLOW TRACT RECONSTRUCTION IN PATIENTS BELOW 1 YEAR OF AGE? CITATION: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY 46 (2014) 961¿966 (DOI:10.1093/EJCTS/EZU080) AUTHORS: KETI VITANOVA, JULIE CLEUZIOU,*, JÜRGEN HÖRERA, JELENA KASNAR-SAMPREC, MANFRED VOGT, CHRISTIAN SCHREIBER AND RÜDIGER LANGE. (B)(4).
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REVIEW THAT A STUDY WAS PERFORMED TO EVALUATE THE DURABILITY OF AND FREEDOM FROM REPLACEMENT BETWEEN HOMOGRAFT, BOVINE JUGULAR VEIN, AND PORCINE-VALVED DACRON CONDUITS USED IN RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) RECONSTRUCTION. THE STUDY POPULATION INCLUDED 145 PATIENTS, ALL YOUNGER THAN ONE YEAR OF AGE, WHOM UNDERWENT RVOT RECONSTRUCTION BETWEEN 1994 AND 2011 AT A SINGLE (B)(6). AMONG ALL PATIENTS, 35 PATIENTS (GENDER NOT PROVIDED, MEAN AGE 4 MONTHS OLD) WERE IMPLANTED WITH A MEDTRONIC BOVINE JUGULAR VEIN VALVED CONDUIT (MEAN SIZE 12-MM, SERIAL NUMBERS NOT PROVIDED), AND 48 PATIENTS (GENDER NOT PROVIDED, MEAN AGE 3.6 MONTHS OLD) WERE IMPLANTED WITH A MEDTRONIC PORCINE-VALVED DACRON CONDUIT (MEAN SIZE 12-MM, SERIAL NUMBERS NOT PROVIDED). ACROSS ALL PATIENTS, 15 EARLY DEATHS OCCURRED (5 DUE TO INTRAOPERATIVE HEART FAILURE, 5 DUE TO PULMONARY HYPERTENSION WITH RIGHT VENTRICLE (RV) FAILURE, 3 DUE TO VENTRICULAR FIBRILLATION, AND 2 DUE TO UNKNOWN CAUSES). OF THESE 15 DEATHS, 4 PATIENTS HAD RECEIVED A MEDTRONIC BOVINE JUGULAR VEIN VALVED CONDUIT AND 4 PATIENTS HAD RECEIVED A MEDTRONIC PORCINE-VALVED DACRON CONDUIT; HOWEVER, NONE OF THE DEATHS WERE ATTRIBUTED TO MEDTRONIC PRODUCT. ACROSS ALL PATIENTS 5 LATE DEATHS OCCURRED (3 DUE TO SEPTIC SHOCK, 1 DUE TO CONVULSIVE SEIZURES, AND 1 DUE TO UNKNOWN CAUSES). OF THESE 5 DEATHS, 3 HAD RECEIVED A MEDTRONIC PORCINE-VALVED DACRON CONDUIT; HOWEVER, NONE OF THE DEATHS WERE ATTRIBUTED TO MEDTRONIC PRODUCT. OF THE PATIENTS IMPLANTED A MEDTRONIC BOVINE JUGULAR VEIN VALVED CONDUIT, OVERALL FREEDOM FROM CONDUIT EXPLANT WAS 59.4% AT 5 YEARS, WHICH INCLUDED 11 EXPLANTS DUE TO VALVULAR STENOSIS, 5 EXPLANTS DUE TO INSUFFICIENCY, AND 1 EXPLANT DUE TO ENDOCARDITIS (AT 5.3 YEARS POST-IMPLANT). OF THE PATIENTS IMPLANTED WITH A MEDTRONIC PORCINE-VALVED DACRON CONDUIT, OVERALL FREEDOM FROM CONDUIT EXPLANT WAS 53.8% AT 5 YEARS, WHICH INCLUDED 19 EXPLANTS DUE TO VALVULAR STENOSIS, 3 EXPLANTS DUE TO INSUFFICIENCY, AND 4 EXPLANTS DUE TO THROMBUS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
ADDITIONAL INFORMATION FROM THE PHYSICIAN AUTHOR STATED THAT MEDTRONIC PRODUCT DID NOT CONTRIBUTE TO ANY DEATHS. REGARDING ADVERSE EVENTS, MEDTRONIC PRODUCTS PERFORMED SIMILAR TO HOMOGRAFTS IN FREEDOM FROM REPLACEMENT AND DURABILITY. OF 145 TOTAL PATIENTS, 79 WERE MALE AND 66 WERE FEMALE. THE MEAN PATIENT WEIGHT WAS 4.4 KG.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 778278 | CONTEGRA | CONDUIT,VALVED,PULMONIC | MWH | MEDTRONIC HEART VALVES DIVISION | 200H12 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00004 MO | Required Intervention |